Arrhythmia & EP Perspective

 
 

  • Paxlovid Rebound in COVID-19: Where We Stand on Drug Regimens   Drs Robert Glatter and Paul Auwaerter discuss Paxlovid rebound and recommendations for patients with COVID-19.
  • A Better Way to Help Patients Drop Excess Weight   No target weights and greater comfort in prescribing anti-obesity medicines are among this expert's strategy.
  • DANCAVAS: Might Cardiovascular Screening Extend Men's Lives?   Drs Melissa Walton-Shirley and Axel Diederichsen discuss the DANCAVAS trial and the impact of screening for cardiovascular disease in men over 60 years.
  • ECG Challenge: Pneumonia Patient With a Rapid Pulse A woman is rushed to the emergency department with symptoms of pneumonia. What does the ECG reveal about her rapid pulse?
  • Bedtime vs Daytime BP Med Dustup: TIME vs HYGIA The TIME study presented at the European Society of Cardiology congress failed to validate the surprising results of the Hygia Chronotherapy Trial.
  • Aug 26 2022 This Week in Cardiology   Early rhythm control in AF, treating coronary artery disease before transcatheter aortic valve implantation, and an ESC 2022 preview are the topics John Mandrola, MD, covers in this week’s podcast.
  • ESC 2022 CAPLA Challenges Expert Opinion on Ablation of Persistent AF A trial presented at the European Society of Cardiology teaches that less is more in ablation for persistent AF and reminds clinicians to demand data before adopting aggressive procedures
  • Post-COVID Symptoms in Kids: Not Always Long COVID   Do kids get long COVID? Look for these unique signs and symptoms.
  • ESC 2022 Mandrola Previews His Top 5 Trials From ESC 2022 Dr John Mandrola gives some insight on his choices for important trials to look for at this weekend's European Society of Cardiology Congress in Barcelona
  • Aug 19 2022 This Week in Cardiology   The obesity paradox in AF and paradoxes in general, digital health gets whacked again, and direct-to-consumer ads are the topics discussed by John Mandrola, MD in this week’s podcast.
  • ESC 2022 Read clinically focused news coverage of key developments from ESC 2022
  • Meta Medicine: Are We Ready for the Mediverse? A virtual trip to a NASA space station has this doctor contemplating the potential of augmented reality in medicine.
  • Aug 12 2022 This Week in Cardiology   AF screening; sodium, potassium, BP, and CV outcomes; drug prices; and cardio-respiratory fitness are the topics John Mandrola, MD, covers in this week’s podcast.
  • Recreation as Rx? Why You Should Prescribe Nature A walk in nature could be just what the doctor ordered, if more physicians would prescribe one rather than drugs.
  • Aug 5 2022 This Week in Cardiology   Hyperkalemia in heart failure, CV health in America, primary prevention ICDs, and a debate about posters at medical meetings are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Post-Arrest Angiography for Non-STE Patients? According to Dr Amal Mattu, post–cardiac arrest patients who lack ST-segment elevation are unlikely to benefit from emergent coronary angiography.
  • Jul 29 2022 This Week in Cardiology   A big new HF and EP trial, doctors and probability, LV assist devices in cardiogenic shock, vitamin D, and exercise in PAD are the topics John Mandrola, MD, discusses in this week’s podcast.
  • The Role of Aspirin Today   Since first being synthesized in 1897, aspirin has become a staple neurologic treatment. It's time to sign the praises of this humble drug, says Dr Christoph Diener.
  • ACEIs vs ARBs: What the Experts Use   Hypertension specialist Dr Jordana Cohen shared her diagnosis and treatment recommendations during a recent Curbsiders podcast.
  • Jul 22 2022 This Week in Cardiology   Therapeutic fashion and conduction system pacing, early rhythm control in AF, statins in CKD, and salt intake in HF are the topics discussed by John Mandrola, MD, in this week’s podcast.